FAF
WST icon

Första AP-fonden’s West Pharmaceutical WST Stock Holding History

Första AP-fonden’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-15,980
Closed -$4.4M – 525
2025
Q4 		$4.4M Sell
15,980
-120
-0.7% -$32.8K 0.03% 426
2025
Q3 		$4.22M Buy
16,100
+1,100
+7% +$267K 0.03% 441
2025
Q2 		$3.28M Sell
15,000
-1,000
-6% -$214K 0.02% 459
2025
Q1 		$3.58M Sell
16,000
-300
-2% -$82.7K 0.03% 448
2024
Q4 		$5.34M Sell
16,300
-300
-2% -$94.4K 0.04% 386
2024
Q3 		$4.98M Sell
16,600
-1,400
-8% -$429K 0.04% 395
2024
Q2 		$5.93M Sell
18,000
-1,400
-7% -$495K 0.05% 318
2024
Q1 		$7.68M Buy
19,400
+4,700
+32% +$1.74M 0.07% 299
2023
Q4 		$5.18M Sell
14,700
-800
-5% -$283K 0.05% 347
2023
Q3 		$5.82M Sell
15,500
-600
-4% -$232K 0.06% 305
2023
Q2 		$6.16M Sell
16,100
-200
-1% -$71.4K 0.07% 309
2023
Q1 		$5.65M Sell
16,300
-26,800
-62% -$7.83M 0.07% 320
2022
Q4 		$10.1M Buy
43,100
+16,400
+61% +$3.89M 0.11% 199
2022
Q3 		$6.57M Buy
26,700
+7,300
+38% +$2.22M 0.08% 274
2022
Q2 		$5.87M Sell
19,400
-11,700
-38% -$3.81M 0.08% 303
2022
Q1 		$12.8M Sell
31,100
-4,000
-11% -$1.57M 0.15% 153
2021
Q4 		$16.5M Buy
35,100
+9,300
+36% +$4M 0.17% 126
2021
Q3 		$11M Sell
25,800
-7,300
-22% -$3.08M 0.12% 190
2021
Q2 		$11.9M Sell
33,100
-6,500
-16% -$2.15M 0.14% 165
2021
Q1 		$11.2M Buy
39,600
+9,100
+30% +$2.6M 0.16% 148
2020
Q4 		$8.64M Buy
30,500
+11,000
+56% +$3.09M 0.13% 172
2020
Q3 		$5.36M Buy
19,500
+7,000
+56% +$1.85M 0.11% 191
2020
Q2 		$2.84M Buy
12,500
+2,100
+20% +$413K 0.07% 291
2020
Q1 		$1.58M Buy
+10,400
New +$1.6M 0.06% 379

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Första AP-fonden's WST Position: Q1 2026 in Review

Första AP-fonden sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 15,980 shares — an estimated $4.4M sold.

Första AP-fonden first reported a position in WST in Q1 2020 and held it in 24 quarters. The position peaked at $16.5M in Q4 2021. 755 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Första AP-fonden reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Första AP-fonden sold 15,980 West Pharmaceutical shares in Q1 2026, an estimated $4.4M.
  • Första AP-fonden first reported a position in West Pharmaceutical in Q1 2020 and held it in 24 quarters.
  • Första AP-fonden's West Pharmaceutical position peaked at $16.5M in Q4 2021.
  • 755 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Första AP-fonden's 13F filing for Q1 2026.